ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

Tom Harkin Is New Chairman f Senate Labor-HS-Education Subcommittee

January 13, 1989

Cooperative Groups Get Reprieve From Cut As Budget Is Flatlined At Fiscal 2006 Level.

June 8, 2007

DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination

October 3, 1986

NCI director recognizes work of staff.

October 17, 2003